 Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR Q3 2022 Results Conference Call August 4, 2022 5:00 PM ET Company Participants Vince Anzalone - VP, IR Christopher Anzalone - President and CEO Javier San Martin - Chief Medical Officer Ken Myszkowski - CFO James Hamilton - SVP, Discovery and Translational Medicine Tracie Oliver - Chief Commercial Officer Patrick OBrien - Chief Operating Officer General Counsel Conference Call Participants Luca Issi - RBC Ted Tenthoff - Piper Sandler Ellie Merle - UBS Joel Beatty - Baird Madhu Kumar - Goldman Sachs Patrick Trucchio - HC Wainwright Keay Nakae - Chardan Mani Foroohar - SVB Securities Mayank Mamtani - B. Riley FBR Prakhar Agarwal - Cantor Operator Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. 